.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
it causes stroke and dementia as well as mood disturbance. svd increases with age but is accelerated by hypertension and diabetes.
.
.